1322085-26-6

Basic information

• Product Name: {3,5-dimethyl-1-[4-(naphthalen-2-ylmethylsulfanyl)-benzyl]-1H-pyrazol-4-yl}-acetic acid
• Synonyms: {3,5-dimethyl-1-[4-(naphthalen-2-ylmethylsulfanyl)-benzyl]-1H-pyrazol-4-yl}-acetic acid
• CAS NO: 1322085-26-6
• Molecular Weight: 416.544
• Mol File: 1322085-26-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: {3,5-dimethyl-1-[4-(naphthalen-2-ylmethylsulfanyl)-benzyl]-1H-pyrazol-4-yl}-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: {3,5-dimethyl-1-[4-(naphthalen-2-ylmethylsulfanyl)-benzyl]-1H-pyrazol-4-yl}-acetic acid(1322085-26-6)
• EPA Substance Registry System: {3,5-dimethyl-1-[4-(naphthalen-2-ylmethylsulfanyl)-benzyl]-1H-pyrazol-4-yl}-acetic acid(1322085-26-6)

Safety Data

• Hazardous Substances Data: 1322085-26-6(Hazardous Substances Data)

Upstream product

• 56699-23-1 (3,5-dimethyl-1H-pyrazol-4-yl)acetic acid methyl ester 
• 1322084-25-2 [1-(4-bromobenzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-acetic acid methyl ester 
• 1076-67-1 2-(mercaptomethyl)naphthalene 
• 939-26-4 2-bromomethylnaphthyl bromide 
• 589-15-1 1-bromomethyl-4-bromobenzene 

Downstream Products

• 1322085-28-8 C₂₅H₂₄N₂O₃S 

Relevant articles and documents

PYRAZOLE COMPOUNDS AS CRTH2 ANTAGONISTS

The present invention relates to pyrazole compounds of formula (I) and pharmaceutically acceptable salts thereof having CRTH2-activity, wherein W, L1, L2, X, L3, Y, R1 and R2 are as defined in the spe